Skip to content

Summit Therapeutics SMMT Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax

Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax at other companies

Flutter Entertainment logo
Flutter EntertainmentFLUT
$0
VMI
Valmont IndustriesVMI
-$3.26M+84.2%
Weyerhaeuser logo
WeyerhaeuserWY
$1M
American Homes 4 Rent logo
American Homes 4 RentAMH
$16.75K
Popular logo
PopularBPOP
Two Harbors Investment Corporation logo
Two Harbors Investment CorporationTWO

Other financials

Income statement

See full
Revenue-
Operating income-$65.6M-81.2%
Net income-$189.4M-201%
EPS (diluted)-$0.24-167%

Balance sheet

See full
Cash & equivalents$8.2M+7.2%
Total debt$20.0M+211%
Total equity$545.9M+58.5%
Total assets$647.9M+68.8%

Cash flow

See full
Operating cash flow-$122.3M-99.9%
CapEx$245.0K-41.9%
Free cash flow-$122.5M-99.0%

Valuation

See full
Market cap$10.67B+3.3%
Enterprise value$10.68B+3.4%

Profitability

See full
Operating margin-268,266.8%-272,316pp
Net margin-271,685%-275,966pp
FCF margin-5,931.6%+4,730pp

Returns & leverage

See full
Return on equity-271%-1,725pp
Debt / equity0.0×
Current ratio7.4×-3.2×

Where this comes from

Reported directly by Summit Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax.

The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Summit Therapeutics's other comprehensive income loss available for sale securities adjustment before reclassification adjustments net of tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Summit Therapeutics's other comprehensive income loss available for sale securities adjustment before reclassification adjustments net of tax?
Summit Therapeutics (SMMT) reported other comprehensive income loss available for sale securities adjustment before reclassification adjustments net of tax of -$176K in Q1 2026.
How has Summit Therapeutics's other comprehensive income loss available for sale securities adjustment before reclassification adjustments net of tax changed year-over-year?
Summit Therapeutics's other comprehensive income loss available for sale securities adjustment before reclassification adjustments net of tax decreased by 32.3% year-over-year, from -$133K to -$176K.
What does other comprehensive income loss available for sale securities adjustment before reclassification adjustments net of tax mean?
The change in market value of investment securities that the company still holds.
How do you interpret other comprehensive income loss available for sale securities adjustment before reclassification adjustments net of tax?
An increase signals positive market performance of the company's investment portfolio, while a decrease signals market-driven depreciation.
How does other comprehensive income loss available for sale securities adjustment before reclassification adjustments net of tax compare across companies?
Common for companies with large cash reserves invested in marketable securities; peers will show similar market-linked fluctuations.